News

DoPersistent fatigue, post-exertion shortness of breath, and lingering exhaustion after overtime work are common sub-health troubles for modern sedentary populations. Many people attribute these symptoms to poor physical fitness, but a 2025 randomized, placebo-controlled clinical trial reveals the core culprit: cellular NADH deficiency. Sufficient NADH for physical fitness supplementation can significantly improve aerobic endurance, cardiorespiratory […]

For decades, observing real-time metabolic changes in deep brain structures has remained a major technical bottleneck in neuroscience research. Traditional imaging tools struggle to balance penetration depth and high-resolution cellular observation, leaving many brain metabolic mechanisms unsolved. Today, NADH brain metabolic imaging breaks this deadlock. As an endogenous fluorescent biomarker and core cellular energy molecule,

NAD+ is an indispensable core coenzyme that dominates cellular redox reactions, energy metabolism, and signal transduction. Its metabolic imbalance is closely linked to multiple chronic diseases and organ dysfunction. While numerous studies have verified that NAD+ precursor supplementation improves tissue repair and metabolic health, the mitochondrial NAD+ liver regeneration regulatory mechanism at the subcellular level

NAD+ anticancer vs oncogenic is one of the most debated questions in metabolic health research. Is NAD+ a cancer promoter or a tumor suppressor? This hotly debated question has sparked widespread confusion among consumers. As the core coenzyme driving all cellular energy metabolism, NAD+ governs mitochondrial ATP synthesis, DNA damage repair, and systemic immune regulation.